Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Anna Sarnelli

Showing results (41-50 of 62) with videos related to

Pageof 7
Sort By:
Radiation Oncology (London, England)|June 26, 2019
Accelerated hypofractionated radiotherapy plus chemotherapy for inoperable locally advanced non-small-cell lung cancer: final results of a prospective phase-II trial with a long-term follow-upElisabetta Parisi, Giovenzio Genestreti, Anna Sarnelli, et al.
Radiation Oncology (London, England)|November 5, 2013
In vitro irradiation system for radiobiological experimentsAnna Tesei, Anna Sarnelli, Chiara Arienti, et al.
Frontiers in Oncology|November 30, 2020
Targeted Alpha Therapy in mCRPC (Metastatic Castration-Resistant Prostate Cancer) Patients: Predictive Dosimetry and Toxicity Modeling of <sup>225</sup>Ac-PSMA (Prostate-Specific Membrane Antigen)Maria Luisa Belli, Anna Sarnelli, Emilio Mezzenga, et al.
Journal of Contemporary Brachytherapy|November 22, 2019
Clinical evidence of abscopal effect in cutaneous squamous cell carcinoma treated with diffusing alpha emitters radiation therapy: a case reportSalvatore Roberto Bellia, Giacomo Feliciani, Massimo Del Duca, et al.
Cell Death & Disease|January 25, 2022
Irradiation causes senescence, ATP release, and P2X7 receptor isoform switch in glioblastomaMichele Zanoni, Alba Clara Sarti, Alice Zamagni, et al.
European Journal of Nuclear Medicine and Molecular Imaging|November 28, 2015
Peptide receptor radionuclide therapy with (177)Lu-DOTATATE in advanced bronchial carcinoids: prognostic role of thyroid transcription factor 1 and (18)F-FDG PETAnnarita Ianniello, Maddalena Sansovini, Stefano Severi, et al.
Molecules (Basel, Switzerland)|February 14, 2019
Dosimetry of <sup>177</sup>Lu-PSMA-617 after Mannitol Infusion and Glutamate Tablet Administration: Preliminary Results of EUDRACT/RSO 2016-002732-32 IRST ProtocolAnna Sarnelli, Maria Luisa Belli, Valentina Di Iorio, et al.
Neuroendocrinology|November 21, 2024
Lu-PRRT Used More Intensively on Advanced Gastro-Entero-Pancreatic and Lung Neuroendocrine Neoplasms: Preliminary Results on Toxicity from a Randomized StudyIlaria Grassi, Silvia Nicolini, Irene Marini, et al.
European Journal of Nuclear Medicine and Molecular Imaging|May 21, 2020
Dosimetry and safety of <sup>177</sup>Lu PSMA-617 along with polyglutamate parotid gland protector: preliminary results in metastatic castration-resistant prostate cancer patientsGiovanni Paganelli, Anna Sarnelli, Stefano Severi, et al.
Frontiers in Medicine|February 9, 2026
Radioligand therapy for primary brain tumors: a PRISMA-based systematic review of meningiomas and gliomasIlaria Grassi, Maddalena Sansovini, Federica Matteucci, et al.
Pageof 7

Showing results (41-50 of 62) with videos related to

Sort By:
Pageof 7
Radiation Oncology (London, England)|June 26, 2019
Accelerated hypofractionated radiotherapy plus chemotherapy for inoperable locally advanced non-small-cell lung cancer: final results of a prospective phase-II trial with a long-term follow-upElisabetta Parisi, Giovenzio Genestreti, Anna Sarnelli, et al.
Radiation Oncology (London, England)|November 5, 2013
In vitro irradiation system for radiobiological experimentsAnna Tesei, Anna Sarnelli, Chiara Arienti, et al.
Frontiers in Oncology|November 30, 2020
Targeted Alpha Therapy in mCRPC (Metastatic Castration-Resistant Prostate Cancer) Patients: Predictive Dosimetry and Toxicity Modeling of <sup>225</sup>Ac-PSMA (Prostate-Specific Membrane Antigen)Maria Luisa Belli, Anna Sarnelli, Emilio Mezzenga, et al.
Journal of Contemporary Brachytherapy|November 22, 2019
Clinical evidence of abscopal effect in cutaneous squamous cell carcinoma treated with diffusing alpha emitters radiation therapy: a case reportSalvatore Roberto Bellia, Giacomo Feliciani, Massimo Del Duca, et al.
Cell Death & Disease|January 25, 2022
Irradiation causes senescence, ATP release, and P2X7 receptor isoform switch in glioblastomaMichele Zanoni, Alba Clara Sarti, Alice Zamagni, et al.
European Journal of Nuclear Medicine and Molecular Imaging|November 28, 2015
Peptide receptor radionuclide therapy with (177)Lu-DOTATATE in advanced bronchial carcinoids: prognostic role of thyroid transcription factor 1 and (18)F-FDG PETAnnarita Ianniello, Maddalena Sansovini, Stefano Severi, et al.
Molecules (Basel, Switzerland)|February 14, 2019
Dosimetry of <sup>177</sup>Lu-PSMA-617 after Mannitol Infusion and Glutamate Tablet Administration: Preliminary Results of EUDRACT/RSO 2016-002732-32 IRST ProtocolAnna Sarnelli, Maria Luisa Belli, Valentina Di Iorio, et al.
Neuroendocrinology|November 21, 2024
Lu-PRRT Used More Intensively on Advanced Gastro-Entero-Pancreatic and Lung Neuroendocrine Neoplasms: Preliminary Results on Toxicity from a Randomized StudyIlaria Grassi, Silvia Nicolini, Irene Marini, et al.
European Journal of Nuclear Medicine and Molecular Imaging|May 21, 2020
Dosimetry and safety of <sup>177</sup>Lu PSMA-617 along with polyglutamate parotid gland protector: preliminary results in metastatic castration-resistant prostate cancer patientsGiovanni Paganelli, Anna Sarnelli, Stefano Severi, et al.
Frontiers in Medicine|February 9, 2026
Radioligand therapy for primary brain tumors: a PRISMA-based systematic review of meningiomas and gliomasIlaria Grassi, Maddalena Sansovini, Federica Matteucci, et al.
Pageof 7